Conclusions
peritoneal metastatic gastric cancer
Intraperitoneal high‐dose paclitaxel with systemic SOX is an effective and tolerable first‐line treatment for patients with peritoneal metastatic gastric cancer and patients with sPCI≤12 scores might be recommended crowd for this regimen as conversion therapy.Systemic SOX and intraperitoneal high‐dose paclitaxel is an effective first‐line treatment for patients with peritoneal metastatic gastric cancer and patients with sPCI≤12 scores might be recommended crowd for this regimen as conversion therapy.
Li Tu and Weihan Zhang contributed equally to this work.